Seoul, South Korea – Award-winning Asia-Pacific specialist CRO Novotechwill attend the 2019 KoNECT conference in Seoul, South Korea this week (Booth #15).
The Novotech CRO South Korea team will attend the conference to meet with local and international biotechs and the local clinical community.
Novotech is the leading and most experienced CRO in the region with a track-record in Asia-Pacific clinical trials spanning 23 years.
KoNECT is a one-of-a-kind conference on clinical trials in Asia, and is co-hosted by Ministry of Food and Drug Safety and supported by Ministry of Health and Welfare.
Novotech CEO Dr John Moller said:
“Novotech has recently welcomed the South Korean Government’s 5-year Plan to further support and speed-up approvals for biotech clinical trials, because it will attract more of Novotech’s US biotech clients to South Korea which already has an outstanding clinical reputation.”